Axios on MSN17 小时
FDA approves Vertex non-opioid pain drug
The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain
Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...
Two biomarkers in the brain could transform how chronic pain is understood and managed
In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
clinicaladvisor.com6 天
Astronauts Experience Acute and Chronic Pain During and After Spaceflight
Researchers assessed physiologic changes of the spine as well as the frequency of low back pain among astronauts during and after spaceflight.
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
EURweb on MSN1 小时
FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
clinicalpainadvisor.com3 天
Chronic Postoperative Pain Remains Common Despite Multimodal Analgesia
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.